Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 91 Pages
Report ld: 4188253
Request Sample
Customized Report
Magnolol Market Size(US$)

CAGR 2025-2031
4.1%
Market Size,2031
USD 75.3
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Magnolol was estimated to be worth US$ 57 million in 2024 and is forecast to a readjusted size of US$ 75.3 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
Magnolol is white fine powder, smells fragrant, spicy flavor, slightly bitter flavor.Magnolol is an extract from Magnolia.
Chemical is an important driver of this industry. Emerging economies, particularly in Asia and Latin America, are experiencing rapid industrialization, urbanization, and population growth. This drives the demand for bulk chemicals across various sectors, including construction, automotive, electronics, agriculture, and consumer goods. The rising middle class in these regions is also contributing to increased consumption of chemical products.
This report aims to provide a comprehensive presentation of the global market for Magnolol, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Magnolol by region & country, by Type, and by Application.
The Magnolol market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Magnolol.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Magnolol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Magnolol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Magnolol in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Magnolol Product Introduction
1.2 Global Magnolol Market Size Forecast
1.2.1 Global Magnolol Sales Value (2020-2031)
1.2.2 Global Magnolol Sales Volume (2020-2031)
1.2.3 Global Magnolol Sales Price (2020-2031)
1.3 Magnolol Market Trends & Drivers
1.3.1 Magnolol Industry Trends
1.3.2 Magnolol Market Drivers & Opportunity
1.3.3 Magnolol Market Challenges
1.3.4 Magnolol Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Magnolol Players Revenue Ranking (2024)
2.2 Global Magnolol Revenue by Company (2020-2025)
2.3 Global Magnolol Players Sales Volume Ranking (2024)
2.4 Global Magnolol Sales Volume by Company Players (2020-2025)
2.5 Global Magnolol Average Price by Company (2020-2025)
2.6 Key Manufacturers Magnolol Manufacturing Base and Headquarters
2.7 Key Manufacturers Magnolol Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Magnolol
2.9 Magnolol Market Competitive Analysis
2.9.1 Magnolol Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Magnolol Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Magnolol as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.9
3.1.2 0.98
3.1.3 Other
3.2 Global Magnolol Sales Value by Type
3.2.1 Global Magnolol Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Magnolol Sales Value, by Type (2020-2031)
3.2.3 Global Magnolol Sales Value, by Type (%) (2020-2031)
3.3 Global Magnolol Sales Volume by Type
3.3.1 Global Magnolol Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Magnolol Sales Volume, by Type (2020-2031)
3.3.3 Global Magnolol Sales Volume, by Type (%) (2020-2031)
3.4 Global Magnolol Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma & Healthcare
4.1.2 Cosmetic & Skin Care
4.1.3 Other
4.2 Global Magnolol Sales Value by Application
4.2.1 Global Magnolol Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Magnolol Sales Value, by Application (2020-2031)
4.2.3 Global Magnolol Sales Value, by Application (%) (2020-2031)
4.3 Global Magnolol Sales Volume by Application
4.3.1 Global Magnolol Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Magnolol Sales Volume, by Application (2020-2031)
4.3.3 Global Magnolol Sales Volume, by Application (%) (2020-2031)
4.4 Global Magnolol Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Magnolol Sales Value by Region
5.1.1 Global Magnolol Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Magnolol Sales Value by Region (2020-2025)
5.1.3 Global Magnolol Sales Value by Region (2026-2031)
5.1.4 Global Magnolol Sales Value by Region (%), (2020-2031)
5.2 Global Magnolol Sales Volume by Region
5.2.1 Global Magnolol Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Magnolol Sales Volume by Region (2020-2025)
5.2.3 Global Magnolol Sales Volume by Region (2026-2031)
5.2.4 Global Magnolol Sales Volume by Region (%), (2020-2031)
5.3 Global Magnolol Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Magnolol Sales Value, 2020-2031
5.4.2 North America Magnolol Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Magnolol Sales Value, 2020-2031
5.5.2 Europe Magnolol Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Magnolol Sales Value, 2020-2031
5.6.2 Asia Pacific Magnolol Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Magnolol Sales Value, 2020-2031
5.7.2 South America Magnolol Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Magnolol Sales Value, 2020-2031
5.8.2 Middle East & Africa Magnolol Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Magnolol Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Magnolol Sales Value
6.2.1 Key Countries/Regions Magnolol Sales Value, 2020-2031
6.2.2 Key Countries/Regions Magnolol Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Magnolol Sales Value, 2020-2031
6.3.2 United States Magnolol Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Magnolol Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Magnolol Sales Value, 2020-2031
6.4.2 Europe Magnolol Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Magnolol Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Magnolol Sales Value, 2020-2031
6.5.2 China Magnolol Sales Value by Type (%), 2024 VS 2031
6.5.3 China Magnolol Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Magnolol Sales Value, 2020-2031
6.6.2 Japan Magnolol Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Magnolol Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Magnolol Sales Value, 2020-2031
6.7.2 South Korea Magnolol Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Magnolol Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Magnolol Sales Value, 2020-2031
6.8.2 Southeast Asia Magnolol Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Magnolol Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Magnolol Sales Value, 2020-2031
6.9.2 India Magnolol Sales Value by Type (%), 2024 VS 2031
6.9.3 India Magnolol Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Hunan NutraMax
7.1.1 Hunan NutraMax Company Information
7.1.2 Hunan NutraMax Introduction and Business Overview
7.1.3 Hunan NutraMax Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Hunan NutraMax Magnolol Product Offerings
7.1.5 Hunan NutraMax Recent Development
7.2 PuroNature Extracts
7.2.1 PuroNature Extracts Company Information
7.2.2 PuroNature Extracts Introduction and Business Overview
7.2.3 PuroNature Extracts Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 PuroNature Extracts Magnolol Product Offerings
7.2.5 PuroNature Extracts Recent Development
7.3 Clover Nutrition
7.3.1 Clover Nutrition Company Information
7.3.2 Clover Nutrition Introduction and Business Overview
7.3.3 Clover Nutrition Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Clover Nutrition Magnolol Product Offerings
7.3.5 Clover Nutrition Recent Development
7.4 Staherb Natural Ingredients
7.4.1 Staherb Natural Ingredients Company Information
7.4.2 Staherb Natural Ingredients Introduction and Business Overview
7.4.3 Staherb Natural Ingredients Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Staherb Natural Ingredients Magnolol Product Offerings
7.4.5 Staherb Natural Ingredients Recent Development
7.5 Yangling Ciyuan Biotech
7.5.1 Yangling Ciyuan Biotech Company Information
7.5.2 Yangling Ciyuan Biotech Introduction and Business Overview
7.5.3 Yangling Ciyuan Biotech Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Yangling Ciyuan Biotech Magnolol Product Offerings
7.5.5 Yangling Ciyuan Biotech Recent Development
7.6 Hunan Huakang Biotech
7.6.1 Hunan Huakang Biotech Company Information
7.6.2 Hunan Huakang Biotech Introduction and Business Overview
7.6.3 Hunan Huakang Biotech Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hunan Huakang Biotech Magnolol Product Offerings
7.6.5 Hunan Huakang Biotech Recent Development
7.7 Hunan Kangshou Pharmaceutical
7.7.1 Hunan Kangshou Pharmaceutical Company Information
7.7.2 Hunan Kangshou Pharmaceutical Introduction and Business Overview
7.7.3 Hunan Kangshou Pharmaceutical Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hunan Kangshou Pharmaceutical Magnolol Product Offerings
7.7.5 Hunan Kangshou Pharmaceutical Recent Development
7.8 Hangzhou Toyond Biotech
7.8.1 Hangzhou Toyond Biotech Company Information
7.8.2 Hangzhou Toyond Biotech Introduction and Business Overview
7.8.3 Hangzhou Toyond Biotech Magnolol Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hangzhou Toyond Biotech Magnolol Product Offerings
7.8.5 Hangzhou Toyond Biotech Recent Development
8 Industry Chain Analysis
8.1 Magnolol Industrial Chain
8.2 Magnolol Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Magnolol Sales Model
8.5.2 Sales Channel
8.5.3 Magnolol Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Magnolol was estimated to be worth US$ 59.13 million in 2025 and is projected to reach US$ 78.03 million, growing at a CAGR of 4.1% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 127
USD 3950.00
(Single User License)
The global Magnolol market was valued at US$ 59.13 million in 2025 and is anticipated to reach US$ 78.03 million by 2032, at a CAGR of 4.1% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 134
USD 2900.00
(Single User License)
The global Magnolol market is projected to grow from US$ 57 million in 2024 to US$ 75.3 million by 2031, at a CAGR of 4.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 144
USD 4900.00
(Single User License)
The global Magnolol market size was US$ 57 million in 2024 and is forecast to a readjusted size of US$ 75.3 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 76
USD 4250.00
(Single User License)
The global market for Magnolol was valued at US$ 57 million in the year 2024 and is projected to reach a revised size of US$ 75.3 million by 2031, growing at a CAGR of 4.1% during the forecast period.
Published Date: 2025-02-24
Pages: 86
USD 2900.00
(Single User License)
Magnolol is white fine powder, smells fragrant, spicy flavor, slightly bitter flavor.Magnolol is an extract from Magnolia.
Published Date: 2024-04-22
Pages: 95
USD 4900.00
(Single User License)
Magnolol is white fine powder, smells fragrant, spicy flavor, slightly bitter flavor.Magnolol is an extract from Magnolia.
Published Date: 2024-01-05
Pages: 93
USD 2900.00
(Single User License)
The global market for Magnolol was estimated to be worth US$ 59.13 million in 2025 and is projected to reach US$ 78.03 million, growing at a CAGR of 4.1% from 2026 to 2032.
Published: 2026-07-15
Pages: 127
The global Magnolol market was valued at US$ 59.13 million in 2025 and is anticipated to reach US$ 78.03 million by 2032, at a CAGR of 4.1% from 2026 to 2032.
Published: 2026-04-28
Pages: 134
The global Magnolol market is projected to grow from US$ 57 million in 2024 to US$ 75.3 million by 2031, at a CAGR of 4.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 144
The global Magnolol market size was US$ 57 million in 2024 and is forecast to a readjusted size of US$ 75.3 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 76
The global market for Magnolol was valued at US$ 57 million in the year 2024 and is projected to reach a revised size of US$ 75.3 million by 2031, growing at a CAGR of 4.1% during the forecast period.
Published: 2025-02-24
Pages: 86
Magnolol is white fine powder, smells fragrant, spicy flavor, slightly bitter flavor.Magnolol is an extract from Magnolia.
Published: 2024-04-22
Pages: 95
Magnolol is white fine powder, smells fragrant, spicy flavor, slightly bitter flavor.Magnolol is an extract from Magnolia.
Published: 2024-01-05
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now